A constitutively active form of neurokinin 1 receptor and neurokinin 1 receptor-mediated apoptosis in glioblastomas-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A constitutively active form of neurokinin 1 receptor and neurokinin 1 receptor-mediated apoptosis in glioblastomas

Published:2009-05 Issue:4 Volume:109 Page:1079-1086
ISSN:0022-3042
Container-title:Journal of Neurochemistry
language:en
Short-container-title:

Author:

Akazawa Toshimasa,Kwatra Shawn G.,Goldsmith Laura E.,Richardson Mark D.,Cox Elizabeth A.,Sampson John H.,Kwatra Madan M.

Publisher

Wiley

Subject

Cellular and Molecular Neuroscience,Biochemistry

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1471-4159.2009.06032.x/fullpdf

Reference46 articles.

1. Substance P provides neuroprotection in cerebellar granule cells through Akt and MAPK/Erk activation: evidence for the involvement of the delayed rectifier potassium current;Amadoro;Neuropharmacology,2007

2. Staurosporine induces apoptosis through both caspase-dependent and caspase-independent mechanisms;Belmokhtar;Oncogene,2001

3. Hemokinin-1 has Substance P-like function in U-251 MG astrocytoma cells: a pharmacological and functional study;Berger;J. Neuroimmunol.,2005

4. Mechanisms of caspase activation;Boatright;Curr. Opin. Cell Biol.,2003

5. Neurokinin 1 receptor and relative abundance of the short and long isoforms in the human brain;Caberlotto;Eur. J. Neurosci.,2003

Cited by 87 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unveiling the Promising Role of Substance P/Neurokinin 1 Receptor in Cancer Cell Proliferation and Cell Cycle Regulation in Human Malignancies;Current Medicinal Chemistry;2024-07-10

2. Neurokinin‐1 receptor antagonist aprepitant regulates autophagy and apoptosis via ROS/JNK in intrahepatic cholangiocarcinoma;Liver International;2024-03-30

3. Advances in synthetic lethality modalities for glioblastoma multiforme;Open Medicine;2024-01-01

4. Fighting Cancer Using Selective Antagonists Targeting the Substance P/Neurokinin-1 Receptor System;Interdisciplinary Cancer Research;2024

5. The Repurposing of Non-Peptide Neurokinin-1 Receptor Antagonists as Antitumor Drugs: An Urgent Challenge for Aprepitant;International Journal of Molecular Sciences;2023-11-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3